Qualigen Therapeutics Inc...

NASDAQ: QLGN · Real-Time Price · USD
1.89
0.13 (7.14%)
At close: Aug 15, 2025, 3:59 PM
1.91
1.06%
After-hours: Aug 15, 2025, 06:37 PM EDT

Qualigen Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-6.36M -12.48M -21.03M -17.9M
Depreciation & Amortization
n/a 4.5K 375.6K 338.28K
Stock-Based Compensation
128.06K 1.1M 5.48M 5.69M
Other Working Capital
-338.44K -491.84K -1.18M 1.68M
Other Non-Cash Items
687.21K -43.86K 3.63M 101.75K
Deferred Income Tax
n/a n/a -271.62K -4.78M
Change in Working Capital
-783.58K 1.11M -1.43M 2.21M
Operating Cash Flow
-6.33M -10.3M -13.25M -14.73M
Capital Expenditures
n/a n/a -319.12K -141.36K
Cash Acquisitions
n/a n/a 135.35K n/a
Purchase of Investments
n/a n/a 9.44K 8.82M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-1.91M 4.22M -9.44K -8.82M
Investing Cash Flow
-1.91M 4.22M -183.76K -141.36K
Debt Repayment
1.48M -550K 2.9M -138.74K
Common Stock Repurchased
n/a n/a -505 n/a
Dividend Paid
-87.6K n/a n/a n/a
Other Financial Acitivies
4.56K n/a 6.67K -247.45K
Financial Cash Flow
9.01M -550K 2.91M 8.43M
Net Cash Flow
772.8K -6.64M -10.5M -6.44M
Free Cash Flow
-6.33M -10.3M -13.57M -14.87M